Last Updated: June 24, 2026

Suppliers and packagers for TOFACITINIB CITRATE

✉ Email this page to a colleague

« Back to Dashboard

TOFACITINIB CITRATE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Hikma	TOFACITINIB CITRATE	tofacitinib citrate	SOLUTION;ORAL	216878	ANDA	Hikma Pharmaceuticals USA Inc.	0054-0821-58	1 BOTTLE in 1 CARTON (0054-0821-58) / 240 mL in 1 BOTTLE	2026-06-03
Ajanta Pharma Ltd	TOFACITINIB CITRATE	tofacitinib citrate	TABLET, EXTENDED RELEASE;ORAL	219542	ANDA	Ajanta Pharma USA Inc.	27241-270-30	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-270-30)	2026-06-03
Aurobindo Pharma Ltd	TOFACITINIB CITRATE	tofacitinib citrate	TABLET, EXTENDED RELEASE;ORAL	218462	ANDA	Aurobindo Pharma Limited	59651-685-30	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-685-30)	2026-06-03
Biocon Pharma	TOFACITINIB CITRATE	tofacitinib citrate	TABLET, EXTENDED RELEASE;ORAL	219442	ANDA	Biocon Pharma Inc	70377-057-11	30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70377-057-11)	2026-06-03
Dexcel	TOFACITINIB CITRATE	tofacitinib citrate	TABLET, EXTENDED RELEASE;ORAL	218668	ANDA	Edenbridge Pharmaceuticals LLC.	42799-970-30	30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (42799-970-30)	2026-06-03
Sinotherapeutics Inc	TOFACITINIB CITRATE	tofacitinib citrate	TABLET, EXTENDED RELEASE;ORAL	216001	ANDA	Padagis US LLC	0574-1811-30	30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0574-1811-30)	2026-06-15
Zydus Pharms	TOFACITINIB CITRATE	tofacitinib citrate	TABLET, EXTENDED RELEASE;ORAL	214264	ANDA	Zydus Pharmaceuticals USA Inc.	70710-1353-3	30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70710-1353-3)	2026-05-20
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.